Benefits and harms of prostate cancer screening – predictions of the ONCOTYROL prostate cancer outcome and policy model

BACKGROUND: A recent recalibration of the ONCOTYROL Prostate Cancer Outcome and Policy (PCOP) Model, assuming that latent prostate cancer (PCa) detectable at autopsy might be detectable by screening as well, resulted in considerable worsening of the benefit-harm balance of screening. In this study,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Public Health
Main Authors: Mühlberger, Nikolai, Boskovic, Kristijan, Krahn, Murray D., Bremner, Karen E., Oberaigner, Willi, Klocker, Helmut, Horninger, Wolfgang, Sroczynski, Gaby, Siebert, Uwe
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5485506/
https://ncbi.nlm.nih.gov/pubmed/28651567
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12889-017-4439-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados